That trial enrolled 338 adults with obesity or overweight without type 2 diabetes, randomized across placebo and four retatrutide dose levels (1 mg, 4 mg, 8 mg, 12 mg weekly), and followed participants for 24 weeks
Market Trend Report Employer Approaches to GLP-1 Coverage December 15, 2025 PHTI For employers, glucagon-like peptide-1 receptor agonists (GLP-1s) for obesity represent an unprecedented healthcare challenge
NICE-appraised licensed alternatives such as semaglutide (Wegovy) and liraglutide (Saxenda) are available through regulated UK weight management services
Retatrutide RUO 20mg is intended for scientific research in laboratory models
These stories illustrate a consistent theme: MEDVi patients feel supported and empowered
And create a simple daily routine that makes consistent eating habits easier to maintain